Why does a breast cancer patient need a Her2 test?
Breast cancer is a common malignant neoplasm in women and is essential for its diagnosis and treatment and for understanding the specific conditions of the patient. Of these, HeR2 (human skin growth factor receptor 2) examination is an essential examination in the diagnosis and treatment of breast cancer. So why does a breast cancer patient need a Her2 test? The HeR2 gene is a gene closely related to the occurrence, development and prognosis of breast cancer. By testing the status of the HeR2 gene, doctors can better understand the patient ‘ s condition and develop more precise treatments. 1. Determination of the severity of the condition: The results of the test are a reflection of the growth and severity of the breast cancer cell and help the doctor to determine the severity of the patient ‘ s condition. 2. Guidance for treatment programmes: Her2-positive breast cancer patients are usually sensitive to some of the target-oriented treatment drugs that can target the expression of the Her2 gene and thus control the growth of the tumor. Thus, through the Her2 examination, the doctor can determine whether the patient is fit to use these targets for treatment. 3. Post-project: Her2 status also predicts the patient ‘ s pro-mortem situation, i.e. the patient ‘ s lifetime and re-emerging risk. This is important for developing treatment programmes and assessing their effectiveness. At present, the most common HER2 testing methods include immunisation, fluorescent in situ hybrid techniques and silver dyeing. These methods are of high accuracy and reliability and can help the doctor to make an accurate assessment of the patient ‘ s Her2 state. In the course of the HER2 examination, the patient should select a regular medical institution and a professional physician to perform the test to ensure the accuracy of the results. At the same time, patients should actively cooperate with the doctor ‘ s recommendations for treatment and follow-up in accordance with the doctor ‘ s guidance. Anyway, it’s very necessary for breast cancer patients to do the Her2 test. By understanding the patient ‘ s HER2 status, doctors can develop more precise treatment programmes to improve the effectiveness of treatment and to extend the patient ‘ s life. At the same time, patients should actively cooperate with the doctor ‘ s recommendations for treatment and follow-up.
